Madrigal Pharmaceuticals Market Sentiment

SPY736.53+0.17%QQQ657.50+0.21%BTC/USD75,859.40+0.15%DIA512.52+0.06%GLD373.37+0.23%TLT81.85−0.09%

Premium Services

Madrigal Pharmaceuticals Inc

MDGLNASDAQ

Trade with Public

$399.63

-0.47-0.12%

Last update: Nov 6, 7:48 PM

Overview Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Earnings: Q3 2026 Earnings were released on Tue Nov 3rd, before the market open

Conference Call: The most recent conference call started at 8:00 AM, 4 days ago

Click to view the webcast

Madrigal Pharmaceuticals Market Sentiment - Benzinga

Madrigal Pharmaceuticals Market Sentiment

Market sentiment signals for Madrigal Pharmaceuticals (MDGL): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 11.2% short float

Options Flow▼ 1.29 P/C ratio

Insider Activity▲ Net Buyer (30d)

Analyst Consensus

Buy

22 analysts

Options Flow (P/C)

1.29

More puts — Bearish

139 calls · 179 puts

Avg Consensus PT

$631

+56.4%

Highest Price Target

$962

+138.5%

Barclays

Lowest Price Target

$382

-5.3%

Citigroup

Short Interest

11.2%

Declining — Bullish

Insider Activity (30d)

Net Buyer

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Nov 4, 2026	Canaccord Genuity	Edward Nash—	+57.0%	$612 → $633	Maintained	Buy
Nov 4, 2026	Truist Securities	Srikripa Devarakonda—	+84.2%	$709 → $743	Maintained	Buy
Nov 3, 2026	Citigroup	Eric Joseph—	+88.5%	$725 → $760	Maintained	Buy
Sep 24, 2026	Goldman Sachs	Andrea Newkirk—	+74.6%	$704	Reinstates	Buy
Sep 23, 2026	Citigroup	Eric Joseph—	+79.8%	$725	Initiate	Buy
Aug 4, 2026	Wolfe Research	Andy Chen—	+50.0%	$605	Upgrade	Peer Perform→Outperform
Aug 3, 2026	Barclays	Eliana Merle—	+138.5%	$964 → $962	Maintained	Overweight
Jul 29, 2026	Canaccord Genuity	Edward Nash—	+45.6%	$578 → $587	Maintained	Buy
Jul 27, 2026	Wells Fargo	Sadia Rahman—	+69.9%	$685	Initiate	Overweight
Jun 11, 2026	B of A Securities	Alexandria Hammond—	+34.4%	$550 → $542	Maintained	Neutral
May 13, 2026	Truist Securities	Srikripa Devarakonda—	+75.8%	$640 → $709	Maintained	Buy
May 7, 2026	Canaccord Genuity	Edward Nash—	+43.3%	$587 → $578	Maintained	Buy
May 7, 2026	Evercore ISI Group	Liisa Bayko—	+60.9%	$652 → $649	Maintained	Outperform
May 6, 2026	HC Wainwright & Co.	Andrew S. Fein—	+53.7%	$620 → $620	Maintained	Buy
Feb 20, 2026	B of A Securities	Alexandria Hammond—	+31.2%	$570 → $529	Maintained	Neutral
Jan 28, 2026	Barclays	Eliana Merle—	+139.0%	$964	Initiate	Overweight
Jan 20, 2026	Citizens	Jonathan Wolleben—	+84.7%	$527 → $745	Maintained	Market Outperform
Dec 19, 2025	Piper Sandler	Yasmeen Rahimi—	+123.2%	$540 → $900	Maintained	Overweight
Dec 11, 2025	B. Riley Securities	William Woods—	+66.1%	$560 → $670	Maintained	Buy
Nov 21, 2025	HC Wainwright & Co.	Andrew S. Fein—	+53.7%	$568 → $620	Maintained	Buy
Nov 20, 2025	Oppenheimer	Jay Olson—	+61.2%	$600 → $650	Maintained	Outperform
Nov 19, 2025	Truist Securities	Srikripa Devarakonda—	+58.7%	$580 → $640	Maintained	Buy
Nov 13, 2025	Canaccord Genuity	Edward Nash—	+45.6%	$526 → $587	Maintained	Buy
Nov 11, 2025	HC Wainwright & Co.	Andrew S. Fein—	+40.8%	$500 → $568	Maintained	Buy
Nov 5, 2025	Cantor Fitzgerald	Prakhar Agrawal—	—	—	Upgrade	Neutral→Overweight

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

People Also Watch

Bulls vs Bears

People Also Watch